
1. sci rep. 2017 jan 20;7:40424. doi: 10.1038/srep40424.

shigatoxin encoding bacteriophage ϕ24b modulates bacterial metabolism raise
antimicrobial tolerance.

holt gs(1), lodge jk(1), mccarthy aj(2), graham ak(1), young g(1), bridge sh(1), 
brown ak(3), veses-garcia m(2), lanyon cv(1), sails a(4), allison he(2), smith
dl(1).

author information: 
(1)faculty health life sciences, northumbria university, newcastle upon
tyne, uk.
(2)microbiology research group, institute integrative biology, university of
liverpool, liverpool, uk.
(3)school medicine, pharmacy health, durham university, durham, uk.
(4)public health england, royal victoria hospital, newcastle upon tyne, uk.

how temperate bacteriophages play role microbial infection disease
progression fully understood. part carrying genes 
promote positive evolutionary selection lysogen. using biolog phenotype
microarrays comparative metabolite profiling demonstrate impact the
well-characterised shiga toxin-prophage ϕ24b escherichia coli host mc1061.
as lysogen, prophage alters bacterial physiology increasing the
rates respiration cell proliferation. first reported study
detailing phage-mediated control e. coli biotin fatty acid synthesis
that rate limiting cell growth. ϕ24b conversion lysogen also
gains increased antimicrobial tolerance chloroxylenol 8-hydroxyquinoline. 
distinct metabolite profiles discriminate mc1061 ϕ24b lysogen 
standard culture, treated 2 antimicrobials. also first 
reported use metabolite profiling characterise physiological impact 
lysogeny antimicrobial pressure. propose temperate phages not
need carry antimicrobial resistance genes play significant role in
tolerance antimicrobials.

doi: 10.1038/srep40424 
pmcid: pmc5247750
pmid: 28106081  [indexed medline]

